Chunxue Wang Selected Research

Leukoaraiosis

11/2014	Factors associated with severity of leukoaraiosis in first-ever lacunar stroke and atherosclerotic ischemic stroke patients.
1/2014	Risk factors of dilated Virchow-Robin spaces are different in various brain regions.
5/2009	Relationship between leukoaraiosis and cerebral large artery stenosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunxue Wang Research Topics

Disease

62	Stroke (Strokes) 01/2022 - 01/2006
42	Ischemic Stroke 01/2022 - 01/2006
13	Transient Ischemic Attack 12/2018 - 05/2008
12	Diabetes Mellitus 05/2018 - 05/2008
8	Pathologic Constriction (Stenosis) 01/2020 - 01/2012
7	Hemorrhage 01/2021 - 06/2006
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2019
5	Atrial Fibrillation 11/2016 - 05/2014
4	Sepsis (Septicemia) 01/2022 - 01/2020
4	Insulin Resistance 01/2020 - 01/2017
4	Cerebral Hemorrhage 05/2018 - 05/2008
4	Prediabetic State (Prediabetes) 01/2018 - 03/2012
4	Hypertension (High Blood Pressure) 06/2014 - 05/2009
3	Neoplasms (Cancer) 08/2022 - 05/2008
3	Chronic Renal Insufficiency 12/2018 - 01/2014
3	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2017 - 05/2015
3	Leukoaraiosis 11/2014 - 05/2009
2	COVID-19 01/2022 - 01/2022
2	Critical Illness (Critically Ill) 09/2021 - 01/2020
2	Cerebral Infarction 01/2021 - 05/2008
2	Wounds and Injuries (Trauma) 01/2020 - 01/2019
2	Infarction (Infarctions) 01/2018 - 03/2012
2	Coronary Disease (Coronary Heart Disease) 05/2014 - 10/2011
2	Atherosclerosis 05/2013 - 01/2012
2	Glucose Intolerance 03/2012 - 05/2010
1	Dysmenorrhea (Menstrual Pain) 10/2022
1	Pain (Aches) 08/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Acidosis 01/2022
1	Shock 01/2022
1	Pulmonary Edema 09/2021
1	Lung Injury 01/2021
1	Fatigue 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Rupture 01/2021
1	Hyperhomocysteinemia 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Alcoholism (Alcohol Abuse) 01/2020
1	Cognitive Dysfunction 01/2018
1	Hyperuricemia 02/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Deglutition Disorders (Dysphagia) 01/2017
1	Heart Failure 02/2016

Drug/Important Bio-Agent (IBA)

19	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2010
13	Clopidogrel (Plavix)FDA Link 01/2021 - 07/2013
12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2006
7	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2016 - 02/2009
5	C-Reactive ProteinIBA 01/2016 - 01/2014
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2016
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 05/2008
4	HDL CholesterolIBA 06/2014 - 01/2013
4	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 05/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2015
3	Uric Acid (Urate)IBA 02/2017 - 03/2014
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017 - 05/2015
3	Indicators and Reagents (Reagents)IBA 01/2017 - 01/2014
3	Blood Glucose (Blood Sugar)IBA 06/2016 - 01/2012
3	Warfarin (Coumadin)FDA LinkGeneric 02/2016 - 05/2014
3	danaparoid (Orgaran)FDA Link 01/2016 - 01/2012
3	oxidized low density lipoproteinIBA 10/2015 - 06/2011
2	Biological ProductsIBA 01/2022 - 01/2022
2	ORALIT (ORS)IBA 01/2022 - 02/2017
2	AlbuminsIBA 09/2021 - 03/2015
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 06/2014
2	Air Pollutants (Pollutants, Air)IBA 01/2020 - 01/2019
2	Cytochrome P-450 CYP2C19IBA 12/2018 - 07/2016
2	LDL CholesterolIBA 10/2015 - 06/2013
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2014 - 01/2013
2	CholesterolIBA 01/2014 - 09/2013
2	LDL Lipoproteins (beta Lipoproteins)IBA 06/2013 - 05/2009
1	Capsules (Microcapsules)IBA 10/2022
1	guizhi-fulingIBA 10/2022
1	Saline SolutionIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	reduningIBA 01/2022
1	Serum AlbuminIBA 09/2021
1	Semaphorin-3AIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Circular RNAIBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	OzoneIBA 01/2020
1	Oxidants (Oxidizing Agents)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Cytidine Triphosphate (CTP)IBA 01/2018
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2015

Therapy/Procedure

20	Therapeutics 08/2022 - 05/2008
5	Secondary Prevention 01/2013 - 01/2006
3	Length of Stay 01/2017 - 03/2014
2	Ligation 01/2021 - 01/2021
2	Thrombolytic Therapy 11/2016 - 06/2011
1	Relaxation Therapy (Relaxation Technique) 01/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022
1	Punctures 01/2021
1	Stroke Rehabilitation 01/2017